Xencor reported $-33975000 in Pre-Tax Profit for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Alnylam Pharmaceuticals ALNY:US $ -274.67M 35.32M
Arrowhead Research ARWR:US $ -72.05M 116.41M
Biogen BIIB:US $ 874.8M 28.6M
Cytokinetics CYTK:US $ -19.82M 66.93M
Epizyme EPZM:US $ -35.74M 19.73M
Karyopharm Therapeutics KPTI:US $ -48941000 7.67M
Macrogenics MGNX:US $ -41.3M 25.14M
Novartis NOVN:VX SF 4129M 217M
Xencor XNCR:US $ -33.98M 57.57M